LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2021

Jan 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2021-01-18

Reporting Person: Morberg John D (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-18	Restricted Stock Unit	$	A	17500	Acquired		Common Stock (17500)	Direct
2021-01-18	Incentive Stock Option (Right to Buy)	$10.83	A	21258	Acquired	2028-01-18	Common Stock (21258)	Direct
2021-01-18	Non-Qualified Stock Option (Right to Buy)	$10.83	A	78742	Acquired	2028-01-18	Common Stock (78742)	Direct

Footnotes

F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2: No exercisable date for this type of award

F3: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock.